Identification of a blood-based biomarker panel for classification of Alzheimer's disease (Q39763684)

14 September 2017

title

Identification of a blood-based biomarker panel for classification of Alzheimer's disease (English)

1 reference

14 September 2017

0 references

0 references

Christoph Laske

1

1 reference

14 September 2017

Thomas Leyhe

2

1 reference

14 September 2017

Elke Stransky

3

1 reference

14 September 2017

Nadine Hoffmann

4

1 reference

14 September 2017

Andreas J Fallgatter

5

1 reference

14 September 2017

Janko Dietzsch

6

1 reference

14 September 2017

publication date

5 April 2011

1 reference

The International Journal of Neuropsychopharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

14

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

1147-1155

1 reference

Alzheimer disease as a vascular disorder: nosological evidence

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Neurovascular mechanisms of Alzheimer's neurodegeneration

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Microvascular injury and blood-brain barrier leakage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

CSF markers for incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

More support for vascular basis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

ROCR: visualizing classifier performance in R

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Macrophage colony-stimulating factor (M-CSF) in plasma and CSF of patients with mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145711000459

1 reference

7 January 2021

Biochemistry and genetics of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145711000459

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000459

7 January 2021

10.1017/S1461145711000459

Identifiers

DOI

1 reference

14 September 2017

1 reference